News Post

Lextox Joins the SYNLAB Group

9th August 2017 – CARDIFF, U.K. – Lextox, a specialist drug, alcohol and DNA testing laboratory, has announced that as of 1st August, it is part of the SYNLAB Group.

SYNLAB International offers a full range of routine and specialist medical laboratory services and is the recognised European leader in human laboratory diagnostic services.

With over 17,000 employees, across more than 30 countries on 4 continents, SYNLAB carries out approximately 450 million laboratory tests per year, achieving sales revenue of circa €1.6 billion.

In the UK, SYNLAB has 11 laboratories and provides services to five NHS hospital Trusts, as well as specialist services for drug and alcohol, food and dialysis testing clients.

SYNLAB Laboratory Services specialises in workplace drug and alcohol testing, training and UK wide collection services for many sectors including logistics, construction, manufacturing and maritime, as well as occupational health providers.

The acquisition of Lextox further extends SYNLAB’s repertoire of drug and alcohol testing services in the UK, offering growth opportunities for both companies, as well as deepening expertise and client offerings in existing and new markets.

SYNLAB was attracted to Lextox due to the dynamism of the company and the management team, its high quality of business and strong value added strategy.

Interested parties can learn more about SYNLAB in the UK at www.synlab.co.uk and can follow the Group’s progress via www.synlab.com.